Roche's New Diabetes Drug Works Better Than Byetta

By wall street journal
Submitted by Amy TenderichCommunity Manager — October 29 at 2:50 pm

Amy Tenderich

Roche's experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. in lowering blood sugar, according to the results of a late stage study.

Read the full article at wsj.com

Report this to a moderator

Comments (2 comments) Add your comment

jayabee52 jayabee52 October 31 at 12:02 am

Decided to do some digging, and found the article without having to subscribel to WSJ & posted it.

jayabee52 jayabee52 October 30 at 11:38 pm

BUMMER! You have to get a subscription to the Wall Street Journal to see more than just the first few lines of the article!